2022 Interview with Dr Matthew O'Connor
Founder of Underdog Pharmaceutical, now renamed Cyclarity Therapeutics, Dr Matthew O'Connor talks about new cyclodextrin-based drugs in development.
Founder of Underdog Pharmaceutical, now renamed Cyclarity Therapeutics, Dr Matthew O'Connor talks about new cyclodextrin-based drugs in development.